Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16
Frequently Asked Questions
What is Market Cap of Intensity Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Intensity Therapeutics Inc market cap is $11.39M.
What is the 52-week high for Intensity Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Intensity Therapeutics Inc 52 week high is $4.18 as of September 18, 2025.
What is the 52-week low for Intensity Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Intensity Therapeutics Inc 52 week low is $0.1853 as of September 18, 2025.
What is Intensity Therapeutics Inc stock price today?
Intensity Therapeutics Inc stock price today is $0.24.
What was Intensity Therapeutics Inc stock price yesterday?
Intensity Therapeutics Inc stock price yesterday was $0.242.
What is the PE ratio of Intensity Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Intensity Therapeutics Inc’s P/E ratio is -0.29.
What is the Price-to-Book ratio of Intensity Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Intensity Therapeutics Inc P/B ratio is 2.8992.
What is the 50-day moving average of Intensity Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Intensity Therapeutics Inc 50-day moving average is $0.2921.
How many employess does Intensity Therapeutics Inc has?